Aug 14, 2023 Wet AMD Outcomes Through the Years Apr 16, 2024 Treatment challenges in patients with nAMD Treatment challenges in patients with nAMD Apr 16, 2024 Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410 Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410 Apr 15, 2024 New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain
